Percutaneous balloon aortic valvuloplasty and coronary angioplasty in a nonagenarian patient with non-ST-segment elevation acute coronary syndrome

Authors

  • Julio C. Echarte Martínez INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Emilio Alfonso Rodríguez. INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Sheila Hechavarria Pouymiró INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Reynol Calderín Pino INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Annerys Martínez Carrillo INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Yudmila R. Borges Moreno INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Olema Martínez Villalonga INSTITUTO CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR LA HABANA
  • Julio C. Echarte Morales

Abstract

Severe aortic stenosis represents a major health problem. Its degenerative origin is the most common cause in adult patients. The atherosclerotic process begins in the aortic annulus and invades the sinuses of Valsalva and commissures, restricting valvular opening.  The most common treatment at present, in selected patients, is the transcatheter aortic valve implantation; but not all health systems can afford this possibility. This article presents the case of a 94-year-old man with a history of chronic ischemic heart disease plus this valve disease, who underwent right coronary angioplasty (due to a 70% de novo ulcerated lesion in the middle segment) and balloon aortic valvuloplasty.

Downloads

Download data is not yet available.

References

1. Akahori H, Tsujino T, Masuyama T, Ishihara M. Mechanisms of aortic stenosis. J Cardiol. 2018;71(3):215-20. DOI: https://doi.org/10.1016/j.jjcc.2017.11.007

2. de Oliveira Sá MP, Cavalcanti LR, Perazzo ÁM, Gomes RA, Clavel MA, Pibarot P, et al. Calcific aortic valve stenosis and atherosclerotic calcification. Curr Atheroscler Rep [Internet]. 2020 [citado 26 Jun 2021];22(2):2. DOI: https://doi.org/10.1007/s11883-020-0821-7

3. Díez-Villanueva P, Arizá-Solé A, Vidán MT, Bonanad C, Formiga F, Sanchis J, et al. Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de la fragilidad en el anciano con cardiopatía. Rev Esp Cardiol. 2019;72(1):63-71. DOI: https://doi.org/10.1016/j.rec.2018.06.035

4. Khanji MY, Ricci F, Galusko V, Sekar B, Chahal CAA, Ceriello L, Gallina S, Kennon S, Awad WI, Ionescu A. Management of aortic stenosis: A systematic review of clinical practice guidelines and recommendations. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):340-53. DOI: https://doi.org/10.1093/ehjqcco/qcab016

5. Pepe M, Larosa C, Rosa I, Biondi-Zoccai G, Nestola PL, Di Cillo O, et al. Degenerative severe aortic stenosis and concomitant coronary artery disease: What is changing in the era of the "Transcatheter Revolution"? Curr Atheroscler Rep [Internet]. 2020 [citado 30 Jun 2021];22(5):17. Disponible en: https://doi.org/10.1007/s11883-020-0835-1

6. Boskovski MT, Gleason TG. Current therapeutic options in aortic stenosis. Circ Res. 2021;128(9):1398-417. DOI: https://doi.org/10.1161/circresaha.121.318040

7. Lax J, Stutzbach P, Beck M, Martín Perea F, Cianciulli T, Grancelli H, et al. Consenso de valvulopatías. Rev Argent Cardiol. 2015;83(Supl 2):1-104.

8. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022;43(7):561-632. DOI: https://doi.org/10.1093/eurheartj/ehab395

9. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2020.

10. Riquenes Cutió O, Domínguez Cruz AM, Infante Vigil-Escalera A. Cuba, ¿una zona azul? Juventud Rebelde. 30 May 2017. Disponible en: https://www.juventudrebelde.cu/cuba/2017-05-30/cuba-una-zona-azul

11. Konishi A, Iwasaki M, Omori T, Shinke T. The effect of multiple-inflation balloon aortic valvuloplasty. Heart Vessels. 2020;35(11):1557-62. DOI: https://doi.org/10.1007/s00380-020-01626-9

12. Williams T, Hildick-Smith DJ. Balloon aortic valvuloplasty: indications, patient eligibility, technique and contemporary outcomes. Heart. 2020;106(14):1102-10. DOI: https://doi.org/10.1136/heartjnl-2019-315904

13. Alkhouli M, Zack CJ, Sarraf M, Bashir R, Nishimura RA, Eleid MF, et al. Morbidity and mortality associated with balloon aortic valvuloplasty: A national perspective. Circ Cardiovasc Interv [Internet]. 2017 [citado 4 Jul 2021];10(5):e004481. Disponible en: https://doi.org/10.1161/circinterventions.116.004481

Downloads

Published

2022-07-31

How to Cite

1.
Echarte Martínez JC, Alfonso Rodríguez. E, Hechavarria Pouymiró S, Calderín Pino R, Martínez Carrillo A, Borges Moreno YR, et al. Percutaneous balloon aortic valvuloplasty and coronary angioplasty in a nonagenarian patient with non-ST-segment elevation acute coronary syndrome. CorSalud [Internet]. 2022 Jul. 31 [cited 2025 Jun. 21];14(2):204-8. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/815

Issue

Vol. 14 No. 2 (2022)

Section

CASE REPORTS

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.